ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,060Medicare Part D Prescriptions Filled, Including Refills

Rank: 489 out of 1844

$490K Total Retail Price of All Prescriptions

Rank: 373 out of 1844

252 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 252 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 252 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 5,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 394 347 1 3
AMLODIPINE BESYLATE 244 225 2 6
SYNTHROID 244 222 2 55
HYDROCODONE-ACETAMINOPHEN 193 159 S3 4 2
OMEPRAZOLE 162 136 5 5
CRESTOR 143 114 6 30
LISINOPRIL 142 129 7 4
METFORMIN HCL ER 139 113 8 46
FENOFIBRATE 133 117 9 71
METOPROLOL SUCCINATE 122 111 10 14
LOSARTAN POTASSIUM 107 92 11 24
FUROSEMIDE 106 93 12 7
WARFARIN SODIUM 104 89 13 13
LEVOTHYROXINE SODIUM 94 80 14 1
ATORVASTATIN CALCIUM 93 80 15 12
HYDROCHLOROTHIAZIDE 89 87 16 9
PANTOPRAZOLE SODIUM 87 55 17 32
SPIRONOLACTONE 85 74 18 60
PRAVASTATIN SODIUM 84 82 19 10
LOSARTAN-HYDROCHLOROTHIAZIDE 79 76 20 47
ISOSORBIDE MONONITRATE ER 77 50 21 59
SERTRALINE HCL 75 71 22 21
SPIRIVA 74 59 23 57
METOPROLOL TARTRATE 72 72 24 11
ZOLPIDEM TARTRATE 72 40 24 23
CARVEDILOL 69 65 26 22
GABAPENTIN 65 52 27 15
CYMBALTA 65 27 27 36
SINGULAIR 62 40 29 102
NAMENDA 61 61 30 33
FLUTICASONE PROPIONATE 59 51 31 50
GLIPIZIDE ER 58 48 32 79
JANUVIA 55 55 33 77
ZETIA 54 52 34 81
RANITIDINE HCL 52 30 35 38
BYSTOLIC 51 46 36 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.